s:

Marking VE Day, PM tells veterans: 'You will always be remembered'

Boris Johnson has declared that the UK's response to the coronavirus demands the same effort and courage as the armed forces showed in the Second World War.




s:

Kawasaki Disease From COVID-19 in Kids: How Common?

(MedPage Today) -- As health organizations have started warning about unusual presentations of a Kawasaki disease-like inflammatory syndrome associated with COVID-19, some pediatric cardiologists noted that even classic cases are likely going undercounted...




s:

OncMadness: Meet the Blue Ribbon Panel

(MedPage Today) -- OncMadness 2020 is upon us. In this first-of-its-kind online education competition in oncology by oncologists, hosted by MedPage Today, 32 oncology hot topics will face off -- only one can be champion! Helping MedPage Today...




s:

Shrunken leagues, virtual Olympics and simulated crowds: What sport might look like post-coronavirus

Coronavirus has changed sport forever. But what will it look like when it comes back?




s:

Off the charts: Online gaming hitting huge numbers during pandemic

With stay-at-home restrictions in place across Australia, online gaming is set to take a big step towards mainstream adoption.




s:

Attention, graduates: Barack and Michelle Obama have a message for you

Former President Obama and First Lady Michelle Obama will deliver commencement speeches as part of virtual graduation ceremonies for the class of 2020.




s:

Southern California Bestsellers: Fiction and nonfiction hardcovers

Southern California Best Sellers, May 10, 2020




s:

The hard-won liberation of Hayley Williams: 'It wasn't beautiful. It was painful'

After 16 years as the frontwoman for Paramore, and following a broken marriage and a lot of therapy, Hayley Williams is releasing her first solo album.




s:

X's John Doe's quarantine staples: vinyl, history books and riding his pretty horses

X was supposed to tour behind its new album "Alphabetland." Now, bassist John Doe is home in Austin with his partner, his two horses nearby: "They keep me sane."




s:

What's on TV Saturday plus Sunday Talk Shows: 'Downton Abbey'

What's on TV Saturday, May 9, plus Sunday Talk Shows: Downton Abbey; coronavirus; movies on TV and more




s:

Cuomo on coronavirus stay-home sacrifices: 'What you're doing is actually saving lives'

New York Gov. Andrew Cuomo acknowledged frustration with coronavirus stay-at-home orders but compared them with past sacrifices during national crises.




s:

Coronavirus: What shape will a recession and recovery take?

Monica Miller explains the alphabet soup of possible recession shapes for the coronavirus-hit global economy.




s:

Coronavirus: Sailors tell of months stuck on ships

Since March, many ports are refusing to allow crew changes or shore leave.




s:

Coronavirus: How African firms are being impacted by the lockdown

With imports slowing, many African nations are learning the importance of local manufacturing.




s:

Coronavirus bailouts: Which country has the most generous deal?

A look at the different ways nations are trying to cushion the blow from the virus shutdowns.




s:

Coronavirus: US unemployment claims hit 33.3 million amid virus

Data shows roughly one-fifth of the US workforce has filed for unemployment benefits since mid-March.




s:

Coronavirus: Passengers told to wear gloves at some UK airports

The owner of Stansted and Manchester airports says passengers must cover their faces and wear gloves.




s:

Coronavirus: Young people are keen to fly again, says airline boss

Wizz Air's József Váradi says budget airlines will be in high demand once the pandemic ends.




s:

Coronavirus: Rail services to be increased as travel restrictions ease

Train operators and the government are planning to increase rail services from mid-May onwards.




s:

Coronavirus: Pandemic sends US jobless rate to 14.7%

US unemployment rises to its highest level since the 1930s as coronavirus devastates the economy.




s:

Tequila and bedsheets: Five popular lockdown buys

A report by the John Lewis group gives a snapshot of what consumers are buying during the pandemic.




s:

Coronavirus: What could a socially-distanced bar look like?

How bars and restaurants could look when coronavirus restrictions are eased.




s:

Coronavirus: Captain Tom Moore graffiti mural in Tamworth

Graffiti artist paints NHS fundraiser Captain Tom on Tamworth wall




s:

Coronavirus: Timelapse of London artist creating NHS mural

Watch the timelapse of artist Lionel Stanhope creating his artwork under London's Waterloo Bridge.




s:

Coronavirus: Michael Palin shares his hospital stories for NHS charity book

The Monty Python shares his lighter moments in hospital, and how humour helps us all.




s:

Coronavirus: Inclusive choir finds voice in lockdown

The Soundabout Inclusive Choir is helping to overcome the isolation felt by some people with special needs.




s:

Serkis: ‘Hobbit reading will take you on an adventure’

Gollum actor Andy Serkis is doing a continuous live reading of The Hobbit for charity.




s:

Coronavirus: Fairgrounds packed up with nowhere to go

Britain's showmen are facing financial ruin as lockdown means fairgrounds rusting away in storage.




s:

M.R. Asks 3 Questions: Pantelis Kalogiros, Co-Founder & VP, Fyusion

Fyusion's technology may not scream “artificial intelligence” to the general public, but it does provide an intuitive, lifelike experience for consumers. It's their consumer-friendly technology that makes Co-Founder, Pantelis Kalogiros's view on purchasing behaviour worth listening to - especially for those integrating AI into their commerce businesses.  

Keep on reading: M.R. Asks 3 Questions: Pantelis Kalogiros, Co-Founder & VP, Fyusion




s:

Quick Answers to Quick Questions: In Conversation with Chris Luttrell, COO, IDology

COO, Chris Luttrell shares her wealth of information about the current state of fraud, what IDology research is revealing about patron's trust and the forecasted impact of recent privacy legislation on consumers and businesses.

Keep on reading: Quick Answers to Quick Questions: In Conversation with Chris Luttrell, COO, IDology




s:

M.R. Asks 3 Questions: Tim Page, CEO, Datrium

CEO at Datrium, Tim Page has a sharpness for how enterprises can protect and prepare their data and operations for disaster recovery - especially when it comes to ransomware.

Keep on reading: M.R. Asks 3 Questions: Tim Page, CEO, Datrium




s:

Quick Answers to Quick Questions: In Conversation with Cal Evans, Senior Consultant, E.I.C.C., Inc.

With 34 years of programming experience in various organizations, Cal shares what he's observed of leaders who are looking to be reinvigorated, what to do when job-inspiration is lost and taking an educated leap of faith.

Keep on reading: Quick Answers to Quick Questions: In Conversation with Cal Evans, Senior Consultant, E.I.C.C., Inc.




s:

Google Cloud vs. AWS: Who Has The Best Pricing?

When evaluating public cloud providers on pricing, it is easy to get hung up on the differences. AWS and Google Cloud each have their own service catalog, terminology and purchasing variations. But do these differences actually impact the final bill?

Keep on reading: Google Cloud vs. AWS: Who Has The Best Pricing?




s:

M.R. Asks 3 Questions: Jay Chapel, CEO, ParkMyCloud

The challenges businesses and services are facing right now vary from wild fluctuations in supply chains; to enormous digital demand on the technologies and platforms that enable us to stay connected and live productive lives. This is why Jay Chapel is looking for ways to help organizations reduce costs across the board. Collecting information from great companies, we hope our conversation shares some ideas that may help in some small way.

Keep on reading: M.R. Asks 3 Questions: Jay Chapel, CEO, ParkMyCloud




s:

Aquadex Ultrafiltration for Critical COVID Patients: Interview with John Erb, CEO at CHF Solutions

As the COVID-19 pandemic continues, many healthcare facilities around the world are inundated with critically ill patients, and resources such as equipment and staff are stretched thin. Shortages of critical equipment, such as ventilators, can mean the difference between life and death for patients, and the need to keep critically ill patients comfortable and alive […]




s:

Boddingtons Plastics: An update

Medical device manufacturer, Boddingtons, has lately been resourcing fast-tooling and moulding projects in relation to emergency procurement for the Covid-19 crisis.




s:

Supreme Court Affirms: High Level of Proof Needed to Invalidate A Patent

Posted by Stephanie Fischer on June 10, 2011 at 3:29pm EDT on BIOtech Now The U.S. Supreme Court issued a favorable decision yesterday in the critical case of Microsoft v. i4i, in which Microsoft challenged the “clear and convincing evidence” standard traditionally used by courts in determining whether to invalidate an issued U.S. patent.   Microsoft argued for a lower “preponderance […]




s:

COVID-19 and Fungal Superinfections: The Deadly, Perfect Storm

Virtually unknown just a few months ago, the COVID-19 pandemic has already resulted in over 239,000 deaths worldwide—including over 67,000 in the United States alone. Now, emerging reports suggest that as many as one third of patients with severe COVID-19 infection requiring intensive care may also be battling another life-threatening infection: invasive aspergillosis, a deadly […]




s:

Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health

Learn how digital tech is accelerating medical breakthroughs by registering your team to attend Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health. While some content focuses on the Boston ecosystem, we’re confident the forum – and virtual networking – will be valuable to a national audience. The May 13, 2020 event will explore the […]




s:

Insurers + PBMs + Specialty Pharmacies + Providers: Will Vertical Consolidation Disrupt Drug Channels in 2020? (rerun)

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs & Payers.

Life was very different when I originally published today’s article. 2020 is not turning out to be quite what any of us expected. However, the pandemic has exposed some intriguing pros and cons of vertical consolidation. Click here to see the original post and comments from December 2019.


The largest insurers, PBMs, and specialty pharmacies have now combined into vertically-integrated organizations. As I explain below, these companies have also been rapidly integrating with healthcare providers.

I also provide an updated look at these companies and highlight strategies that they are using—or could use—to control the channel. I believe that these insurer / PBM / specialty pharmacy / provider organizations are poised to restructure U.S. drug channels by exerting greater control over patient access, sites of care/dispensing, and pricing.

If they can effectively coordinate their sprawling business operations, they will pose a substantial threat of disruption to the existing commercial strategies of pharma companies.

Will they succeed by better managing care and costs, or merely by extracting higher profits from our convoluted system?
Read more »
        




s:

Express Scripts + Prime Therapeutics: Our Four Takeaways From This Market Changing Deal (rerun)

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs & Payers.

I suspect this deal will remain profitable for the participating companies even as COVID-19 alters the US. prescription payer mix. Click here to see the original post and comments from January 2020. National market shares for the largest PBMs in 2019 appears as Exhibit 88 of our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

P.S. Sorry that today's meme is one day too late for Star Wars day.



Just before the holidays, Cigna’s Express Scripts business announced a market-changing deal with Prime Therapeutics. Click here to read the press release.

There's been very little written about this transaction, though it has potentially major implications. Below, I share my thoughts on the following topics arising from the deal:
  • Implications for manufacturers and pharmacies
  • The role of the secretive Ascent Health Services
  • What this all means for Walgreens
  • Why the Federal Trade Commission won’t challenge the deal
A few weeks ago, I explained why integrated insurer / PBM / specialty pharmacy / provider organizations are poised to restructure U.S. drug channels. The Express Scripts / Prime deal signals that the channel will continue its amazing pace of reinvention.

The scale, scope, and interconnectedness of today’s market participants make the system increasingly resistant to massive disruption from either external players like Amazon or a government takeover. Like it or not, the channel will continue to gain power and extract profit. Read on and see if you agree.
Read more »
        




s:

Federal agency finds 'reasonable grounds to believe' Rick Bright's whistleblower claims: NYT

Only days after former BARDA chief Rick Bright filed a whistleblower complaint alleging retaliation by the Trump administration, the U.S. Office of the Special Counsel has recommended his temporary reinstatement, the New York Times reports.




s:

Assistant Attorney General Thomas E. Perez Speaks at the Conference on the Transformation of Security and Fundamental Rights Legislation – Rights and Responsibilities: Between Hope and Challenges on “Legislating National Harmony”

"Our Declaration of Independence declared in 1776 that “all men are created equal,” but it took 100 years and a civil war that took hundreds of thousands of lives to end slavery; another hundred years to create legal equality for African Americans; and we struggle to this day to make equality a reality. I see this every day in my work as the chief civil rights law enforcement official for the United States," said Assistant Attorney General Perez.




s:

Deputy Attorney General James M. Cole Delivers Remarks at the “Pills to Needles: the Pathway to Rising Heroin Deaths” Event

As the Attorney General recently observed, heroin and opiate addiction and abuse “is impacting the lives of Americans in every state, in every region, and from every background and walk of life.”




s:

Attorney General Holder Delivers Remarks at the Focus: Hope “Heroes for Hope” Event

Ultimately, as your history reminds us, these efforts will be successful only if we take responsibility not just for ourselves, but for our families, our neighbors, our friends, and our fellow citizens. Among them are the future “heroes for hope” that this city, this state, and this country desperately need.




s:

Consideration for ongoing clinical trials: Ensuring Participant Safety and Adapting New Processes during COVID‑19 Pandemic

By Ashley Henderson, PhD, CATO SMS Scientist 1.0 INTRODUCTION The COVID‑19 pandemic has added an unprecedented set of challenges to the conduct of clinical trials including quarantines, travel limitations, site closures, and interruptions in the supply chain of investigational products. In acknowledgement of these challenges, the Food and Drug Administration (FDA) recognizes that protocol modifications …

Continue reading »




s:

America's Opioid Crisis: Outpatient Treatment is Effective and Accessible

More than 2 million Americans suffer from opioid use disorder, but only about 25% of people receive any sort of care. For many, inpatient treatment often means leaving a job and loved ones behind to seek recovery.




s:

Coronavirus Testing Delays in the United States: What Happened?

Testing for the novel coronavirus in the United States has not kept pace with the enormous demand despite national efforts to ramp up capacity.




s:

Recipe For Managing Data Disclosure Successfully With Academic Partners: A Public Gene Therapy Company Perspective

This blog post was written by Deanna Petersen, CBO of AVROBIO, as part of the From The Trenches feature of LifeSciVC. When AVROBIO went public in June 2018, I found myself on the steep end of an unexpected but interesting

The post Recipe For Managing Data Disclosure Successfully With Academic Partners: A Public Gene Therapy Company Perspective appeared first on LifeSciVC.




s:

ExcelVite Wins Two Gold Awards: Best Innovation and Best Global Market

In the 8th edition of The Star Outstanding Business Awards (SOBA), ExcelVite has emerged as Gold winner for two award categories–Best Innovation and Best Global Market.